Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002)
- PMID: 15313535
- DOI: 10.1016/j.diagmicrobio.2004.04.007
Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002)
Abstract
Metallo-beta-lactamases (M beta L) were initially characterized in Japan, usually of the IMP-type, and found in Pseudomonas aeruginosa (PSA), Acinetobacter spp. (ACB), or Serratia marcescens (SM). The number of M beta L types has increased worldwide, but geographic dissemination within Japan has appeared limited. This study compares baseline levels of M beta L resistance from two 22-center studies (1996-1997) to the longitudinal sample (3 sites) of Japanese isolates from the SENTRY Antimicrobial Surveillance Program (1998-2002). All minimal inhibitory concentration results were determined by reference methods. A total of 26.8% PSA, 3.4% ACB, and 3.1% Enterobacteriaceae (enterobacters and SM) with resistance to monitored carbapenems (CARB) (minimal inhibitory concentration, > or =8 microg/mL) were screened for M beta L production by disk approximation tests (EDTA and 2-MPA inhibitors), CARB hydrolysis by enzyme extracts, and selected PCR primers for known M beta L types. All M beta L-positive strains (10) were sequenced to determine enzyme identification. Clonality in each center was determined by automated ribotyping and PFGE. The CARB susceptibility rates in PSA decreased (80.7% to 62.0%) over the monitored interval (1998-2002), but varied by medical center location. Among CARB-resistant isolates, 10.8% were attributed to M beta L strains (1.1% of all PSA tested). M beta L identification showed the following: five PSA (three IMP-1, two IMP-2), four SM (one IMP-1, two IMP-1 + OXA-1, and one IMP-11). Also a single ACB had an IMP-1. Eight of 10 M beta L isolations occurred between 2000 and 2002; four occurred in 2002. BRL42715, an AMP-C inhibitor, confirmed AMP-C-mediated resistance in 87.3% of PSA, and outer membrane protein changes were also discovered by membrane studies. Prior results (22 sites, 1997-1998) showed CARB resistance at 22.4-25.6% and 0.5-0.9% M beta Ls (IMP-1) overall; it was slightly elevated in this SENTRY Program sample. In conclusion, M beta L-producing strains from several species persist in Japan, but represent a distinct minority of all CARB-resistant strains (1998-2002). Although M beta L rates appear generally stable in Japan, continued surveillance for these mechanisms seems to be a prudent practice, because of the mobility of the genetic determinants and the emergence of novel enzyme types, especially among the Enterobacteriaceae.
Comment in
-
Emerging epidemic of metallo-beta-lactamase-mediated resistances.Diagn Microbiol Infect Dis. 2005 Feb;51(2):77-84. doi: 10.1016/j.diagmicrobio.2004.07.003. Diagn Microbiol Infect Dis. 2005. PMID: 15698711 No abstract available.
Similar articles
-
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.Int J Antimicrob Agents. 2005 Jan;25(1):57-61. doi: 10.1016/j.ijantimicag.2004.08.013. Int J Antimicrob Agents. 2005. PMID: 15620827
-
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).Diagn Microbiol Infect Dis. 2004 Jul;49(3):211-6. doi: 10.1016/j.diagmicrobio.2004.03.016. Diagn Microbiol Infect Dis. 2004. PMID: 15246512
-
Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program.Diagn Microbiol Infect Dis. 2004 Aug;49(4):231-6. doi: 10.1016/j.diagmicrobio.2004.03.014. Diagn Microbiol Infect Dis. 2004. PMID: 15313526
-
[Gram-negative bacteriae with resistance to carbapenems].Med Sci (Paris). 2010 Nov;26(11):950-9. doi: 10.1051/medsci/20102611950. Med Sci (Paris). 2010. PMID: 21106177 Review. French.
-
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.Int J Med Microbiol. 2010 Aug;300(6):371-9. doi: 10.1016/j.ijmm.2010.04.005. Epub 2010 May 27. Int J Med Microbiol. 2010. PMID: 20537585 Review.
Cited by
-
Efficacy of calcium-EDTA as an inhibitor for metallo-β-lactamase in a mouse model of Pseudomonas aeruginosa pneumonia.Antimicrob Agents Chemother. 2010 Nov;54(11):4582-8. doi: 10.1128/AAC.00511-10. Epub 2010 Aug 16. Antimicrob Agents Chemother. 2010. PMID: 20713659 Free PMC article.
-
Antimicrobial Resistance Surveillance and New Drug Development.Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S5-S13. doi: 10.1093/ofid/ofy345. eCollection 2019 Mar. Open Forum Infect Dis. 2019. PMID: 30895210 Free PMC article.
-
Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates.J Clin Microbiol. 2008 Jun;46(6):2028-37. doi: 10.1128/JCM.00818-07. Epub 2008 Mar 5. J Clin Microbiol. 2008. PMID: 18322055 Free PMC article.
-
Metallo-beta-lactamase-producing Pseudomonas spp. in Korea: high prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type.Yonsei Med J. 2009 Jun 30;50(3):335-9. doi: 10.3349/ymj.2009.50.3.335. Epub 2009 Jun 23. Yonsei Med J. 2009. PMID: 19568593 Free PMC article.
-
Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.Antimicrob Agents Chemother. 2015 Dec;59(12):7299-307. doi: 10.1128/AAC.01651-15. Epub 2015 Sep 14. Antimicrob Agents Chemother. 2015. PMID: 26369960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous